Yayın: Design, synthesis, and biological activity of a novel series of 2,5-disubstituted furans/pyrroles as HIV-1 fusion inhibitors targeting gp41
| dc.contributor.author | Avan, İlker | |
| dc.contributor.author | Srinivasa R. Tala | |
| dc.contributor.author | Hong Lü | |
| dc.contributor.author | Peng Zou | |
| dc.contributor.author | İlker Avan | |
| dc.contributor.author | Tarek S. Ibrahim | |
| dc.contributor.author | Nader E. Abo‐Dya | |
| dc.contributor.author | Abdelmotaal Abdelmajeid | |
| dc.contributor.author | Asim K. Debnath | |
| dc.contributor.author | Alan R. Katritzky | |
| dc.contributor.orcid | 0000-0001-8283-7135 | |
| dc.contributor.orcid | 0000-0001-5593-6533 | |
| dc.contributor.orcid | 0000-0002-9798-5242 | |
| dc.contributor.orcid | 0000-0002-0816-0610 | |
| dc.contributor.orcid | 0000-0002-3049-4617 | |
| dc.contributor.orcid | 0000-0003-2761-0506 | |
| dc.date.accessioned | 2025-11-13T09:57:24Z | |
| dc.date.issued | 2011-09-07 | |
| dc.identifier.doi | https://doi.org/10.1016/j.bmcl.2011.08.081 | |
| dc.identifier.endpage | 6898 | |
| dc.identifier.issn | 0960-894X | |
| dc.identifier.issue | 22 | |
| dc.identifier.openalex | W1968093211 | |
| dc.identifier.startpage | 6895 | |
| dc.identifier.uri | https://hdl.handle.net/11421/2715 | |
| dc.identifier.uri | https://doi.org/10.1016/j.bmcl.2011.08.081 | |
| dc.identifier.volume | 21 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Bioorganic & Medicinal Chemistry Letters | |
| dc.rights | restrictedAccess | |
| dc.subject | Chemistry | |
| dc.subject | Gp41 | |
| dc.subject | Cytotoxicity | |
| dc.subject | Human immunodeficiency virus (HIV) | |
| dc.subject | Enfuvirtide | |
| dc.subject | Combinatorial chemistry | |
| dc.subject | Stereochemistry | |
| dc.subject | Chemical synthesis | |
| dc.subject | Knoevenagel condensation | |
| dc.subject | Pyridazine | |
| dc.subject | Biochemistry | |
| dc.subject | In vitro | |
| dc.subject | Virology | |
| dc.subject.sdg | 3 | |
| dc.title | Design, synthesis, and biological activity of a novel series of 2,5-disubstituted furans/pyrroles as HIV-1 fusion inhibitors targeting gp41 | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5005564730 |
